Polycystic ovary syndrome: Evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 2, 1998, Pages 582-590

  Pastor, Carmen L ^a,c   Griffin Korf, Marie L ^a   Aloi, Joseph A ^a   Evans, William S ^a   Marshall, John C ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROGESTERONE; PROLACTIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; HYPOTHALAMUS; IMMUNORADIOMETRIC ASSAY; INTRAVAGINAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUTEINIZING HORMONE RELEASE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PULSE GENERATOR; RADIOIMMUNOASSAY; TRANSDERMAL DRUG ADMINISTRATION;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPOTHALAMUS; KINETICS; LUTEINIZING HORMONE; PERIODICITY; POLYCYSTIC OVARY SYNDROME; PROGESTERONE;

FALLOPIA;

EID: 0031765313     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.2.582     Document Type: Article

References (57)

1. Stein IF, Leventhal ML. 1935 Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 29:181-191.
2. Franks S. 1995 The polycystic ovary syndrome. N Engl J. Med. 333:853-861.
3. Utiger RD. 1996 Insulin and the polycystic ovary syndrome. N Engl J Med. 335:657-658.
4. Poretsky L, Piper B. 1994 Insulin resistance, hypersecretion of LH and a dual defect hypothesis for the pathogenesis of PCOS. Obstet Gynecol. 84:613-621.
5. Ehrman DA, Barnes R, Rosenfield RL. 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev. 16:322-352.
6. Rebar RW, Judd HL, Yen SSC, Rakoff J, Vandenberg G, Naftolin F. 1976 Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest. 57:1320-1329.
7. Yen SSC, Vela P, Rankin J. 1970 Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab. 30:435-442.
8. Waldstreicher J, Santoro NF, Hall JE, Filicori M, Crowley WF. 1988 Hyperfunction of the hypothalamic-pituitary axis in women with PCO. J Clin Endocrinol Metab. 66:165-172.
9. Berga SL, Guzick DS, Winters SJ. 1993 Increased LH and a subunit secretion in women with hyperandrogenemic anovulation. J Clin Endocrinol Metab 77:895-901.
10. Kazer RR, Kessel B, Yen SSC. 1987 Circulating LH pulse frequency in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 65:233-236.
11. Taylor AE, McCourt B, Martin KA, et al. 1997 Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab. 82:2248-2256.
12. Chang RJ, Laufer LR, Meldrum DR, Judd HL. 1983 Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist J Clin Endocrinol Metab. 56:897-903.
13. Yen SSC, Chaney C, Judd HL. 1976 The endocrine function of the human ovary. New York: Academic Press; 273.
14. Chang RJ, Manfdel FP, Lu JK, Judd HL, 1982 Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease. J Clin Endocrinol Metab. 54:490-495.
15. Nestler JE, Jacobowicz DJ. 1996 Decreases in ovarian cytochrome P450 c17α activity and serum free testosterone after reduction of insulin secretion in PCOS. N Engl J Med. 335:617-623.
16. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R. 1996 The insulin sensitizing agent Troglitazone improves metabolic and reproductive abnormalities in PCOS. J Clin Endocrinol Metab. 81:3299-3306.
17. Acbay O, Gundogdu S. 1996 Can metformin reduce insulin resistance in PCOS. Fertil Steril. 65:946-949.
18. Guzick DS, Wing R, Smith D, Berga SL, Winters SJ. 1994 Endocrine consequences of weight loss in obese hyperandrogenic anovulatory women. Fertil Steril. 61:598-604.
19. Ehrman DA, Cavaghan MK, Imperial J, Sturgis J, Rosenfield RL, Polansky KS. 1997 Effects of metformin on insulin secretion, insulin action and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 82:524-530.
20. Barnes RB, Rosenfield RL, Ehrman DA, et al. 1994 Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab. 79:1328-1333.
21. Lobo RA, Goebelsmann U. 1982 Effect of androgen excess on inappropriate gonadotropin secretion as found in PCOS. Am J Obstet Gynecol. 142:394-401.
22. Dunaif A, Scully RN, Wiser WL, Chapin DS, Crowley WF. 1984 The effect of continuous androgen secretion on the hypothalamic pituitary axis in women: evidence from a luteinized thecoma of the ovary. J Clin Endocrinol Metab. 59:389-393.
23. Serafini P, Silva PD, Paulson RJ, Elkind-Hirsch K, Hemandez M, Lobo RA. 1986 Acute modulation of hypothalamic-pituitary axis by intravenous testosterone in normal women. Am J Obstet Gynecol. 155:1288-1292.
24. Spinder T, Spijkstra JJ, Van Den Tweel, et al. 1989 The effect of long term testosterone administration on pulsatile LH secretion and ovarian histology in eugonadal female to male transsexuals. J Clin Endocrinol Metab. 69:151-156.
25. Barkan AL, Cassorla F, Loriaux DL, Kelch RP, Marshall JC. 1984 Steroid and gonadotropin secretion in a patient with viralization due to a lipoid cell ovarian tumor. Obstet Gynecol. 63:287-295.
26. Apter D, Butzow T, Laughlin GA, Yen SSC. 1994 Accelerated 24-h LH pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of PCOS. J Clin Endocrinol Metab. 79:119-125.
27. Apter D, Vihko R. 1990 Endocrine determinants of fertility: serum androgen concentrations during follow up of adolescents into the third decade of life. J Clin Endocrinol Metab. 71:970-974.
28. Spratt DI, Finkelstein JS, Butler JP, Badger TM, Crowley WF. 1987 Effects of increasing frequency of low doses of GnRH on gonadotropin secretion in GnRH deficient men. J Clin Endocrinol Metab. 64:1179-1186.
29. Gross KM, Matsumoto AM, Bremner WJ. 1987 Differential control of LH and FSH secretion by LHRH pulse frequency in man. J Clin Endocrinol Metab. 64:675-680.
30. Soules MR, Clifton DK, Bremner WJ, Steiner RA. 1987 Corpus luteum insufficiency induced by a rapid GnRH induced gonadotropin secretion pattern in the follicular phase. J Clin Endocrinol Metab. 65:457-464.
31. Christman GM, Randolph JF, Kelch RP, Marshall JC. 1991 Reduction of GnRH pulse frequency is associated with subsequent selective FSH secretion in women with polycystic ovarian disease. J Clin Endocrinol Metab. 72:1278-1285.
32. Veldhuis JD, Johnson ML. 1986 Cluster analysis: a simple, versatile and robust algorithm for endocrine pulse detection. Am J Physiol. 250:E486-E493.
33. Buckler HM, Phillips SE, Cameron IT, Healy DL, Burger HG. 1988 Vaginal progesterone administration before ovulation induction with gonadotropins in PCOS. J Clin Endocrinol Metab. 67:300-306.
34. Berga SL, Yen SSC. 1989 Opioidergic regulation of LH pulsatility in women with PCOS. Clin Endocrinol (Oxf). 30:177-184.
35. Wildt L, Hausler A, Marshall G, et al. 1981 Frequency and amplitude of GnRH stimulation and gonadotropin secretion in the rhesus monkey. Endocrinology. 109:376-385.
36. Dalkin AC, Haisenleder DJ, Ortolano GA, Ellis T, Marshall JC. 1989 The frequency of gonadotropin-releasing hormone (GnRH) stimulation differentially regulates gonadotropin subunit mRNA expression. Endocrinology. 125:917-924.
37. Haisenleder DJ, Dalkin AC, Ortolando GA, Marshall JC, Shupnik MA. 1991 A pulsatile GnRH stimulus is required to increase transcription of the gonadotropin subunit genes: evidence for differential regulation of transcription by pulse frequency in vivo. Endocrinology. 128:1278-1285.
38. Reame N, Sauder SE, Kelch RP, Marshall JC. 1984 Pulsatile gonadotropin secretion during the human menstrual cycle-evidence for altered frequency of GnRH secretion. J Clin Endocrinol Metab. 59:328-338.
39. Filicori M, Santoro N, Merriam GR, Crowley WF. 1986 Characterization of the physiologic pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab. 62:1136-1144.
40. Soules MR, Steiner RA, Clifton DK, Cohen NL, Aksel S, Bremner WJ. 1984 Progesterone modulation of pulsatile luteinizing hormone in normal women. J Clin Endocrinol Metab. 58:378-383.
41. Nippoldt TB, Reame NE, Kelch RP, Marshall JC 1989 The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle. J Clin Endocrinol Metab. 69:67-76.
42. Gindoff PR, Jewelewicz R, Hembree W, Wardlaw S, Ferin M. 1988 Sustained effects of opioid antagonism during the normal human luteal phase. J Clin Endocrinol Metab. 66:1000-1004.
43. Clayton RN, Royston JP, Chapman J, et al. 1987 Is changing hypothalamic activity important for control of ovulation. Br Med J. 295:7-12.
44. Daniels TL, Berga SL. Resistance of GnRH drive to sex steroid-induced suppression in hyperandrogenemic anovulation [Abstract P2-612]. Proc of the 78th Annual Meet of The Endocrine Soc. 1996.
45. Venturoli S, Porcu E, Fabri R, et al. 1992 Longitudinal evaluation of different gonadotropin pulsatile patterns in anovulatory cycles of young girls. J Clin Endocrinol Metab. 74:836-841.
46. Zumoff B, Freeman R, Coupey S. 1983 A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic ovary syndrome. N Engl J Med. 309:1206-1209.
47. Apter D. 1980 Serum steroids and pituitary hormones in female puberty: a partly longitudinal study. Clin Endocrinol (Oxf). 12:107-113.
48. Dunaif A, Mandeli J, Fluhr H, Dobtjansky A. 1988 The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in PCOS. J Clin Endocrinol Metab. 66:131-139.
49. Morales AJ, Laughlin GA, Butzow T, Maleshwari H, Baumann C, Yen SSC. 1996 Insulin, somototropic and LH axes in lean and obese women with PCOS: common and distinct features. J Clin Endocrinol Metab. 81:2854-2864.
50. Adashi E, Hsueh A, Yen SS. 1981 Insulin enhancement of LH and FSH levels by cultured pituitary cells. Endocrinology. 108:1441-1449.
51. 125I IGF-1 binding in the rat. Endocrinology. 122:581-585.
52. Dunaif A, Graf M. 1989 Insulin administration alters gonadal steriod metabolism independent of changes in gonadotropin secretion in insulin resistant women with the polycystic ovary syndrome. J Clin Invest. 83:23-29.
53. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. 1986 Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 62:904-910.
54. Nestler JE, Barlascini CO, Matt DW, et al. 1989 Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with PCOS. J Clin Endocrinol Metab. 68:1027-1032.
55. Melrose P, Gross L. 1987 Steroids effect the secretory modalities of GnRH release. Endocrinology. 121:190-199.
56. Dunaif A. 1986 Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome? J Clin Endocrinol Metab. 63:215-221.
57. Sir-Petermann T, Raberbauer B, Wildt L. 1993 The effect of flutamide on pulsatile gonadotropin secretion in hyperandrogenemic women. Hum Reprod. 8:1807-1812.